Company intelligence / Profile preview

PELOBiotech

Planegg/Martinsried, Bavaria, Germany

Ownership: Private
Development stage: Other

Overview

PELOBiotech provides a broad portfolio of research products for cell and gene therapy, regenerative medicine, 3D cell culture, and primary/stem cell research; not a clinical-stage drug developer[1][3][4].

Modalities: Cell therapyStem cell therapy3D cell culture modelsGenetically modified cell systemsRecombinant protein (via media and supplement support)
Industry: Non-Drug Biotech

Partnerships

VitaCyte (exclusive Europe distributor for collagenase and protease)Akron BiotechirisbiosciencesBioLifeSolutionsHelios BioScience (GMP products and reagents)GenXProirisbiosciencesReachBio Research Labs (various R&D and manufacturing collaborations)

Beyond the preview

Go deeper on PELOBiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PELOBiotech.

Explore the full profile